X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
2.830
0.00 (0.00%)
At close: Oct 2, 2026, 4:00 PM EDT
2.800
-0.030 (-1.06%)
After-hours: Oct 2, 2026, 7:30 PM EDT
X4 Pharmaceuticals Market Cap
X4 Pharmaceuticals has a market cap or net worth of $280.59 million as of October 2, 2026. Its market cap has increased by 245.26% in one year.
Market Cap
280.59M
Enterprise Value
149.84M
1-Year Change
245.26%
Ranking
Category
Stock Price
$2.83
ChartMarket Cap Chart
Since March 14, 2019, X4 Pharmaceuticals's market cap has increased from $101.77M to $280.59M, an increase of 175.70%. That is a compound annual growth rate of 14.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 280.59M | -19.77% |
| Dec 31, 2025 | 349.75M | 179.54% |
| Dec 31, 2024 | 125.11M | -10.81% |
| Dec 29, 2023 | 140.27M | 16.23% |
| Dec 30, 2022 | 120.68M | 87.36% |
| Dec 31, 2021 | 64.41M | -38.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Century Therapeutics | 298.77M |
| Abeona Therapeutics | 295.07M |
| EyePoint | 294.85M |
| Clinuvel Pharmaceuticals | 294.75M |
| SAB Biotherapeutics | 292.98M |
| Fate Therapeutics | 285.17M |
| Rocket Pharmaceuticals | 284.32M |
| Upstream Bio | 284.26M |